+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Arbovirus Testing Market Size, Share & Trends Analysis Report by Type (ELISA-Based Tests, RT-PCR Based Tests), End-use (Diagnostic Laboratories, Hospitals, Research Centers), Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 110 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 6085864
Description Jump to:
The Arbovirus Testing Market was valued at USD 1.12 Billion in 2024, and is projected to reach USD 1.43 Billion by 2030, rising at a CAGR of 4.50%. The rising incidence of arboviral diseases such as Zika, dengue, and West Nile is fueling the demand for robust testing solutions. The increasing prevalence of these diseases in various regions has heightened the need for accurate diagnostics to manage outbreaks effectively. Increased awareness among the public and healthcare systems has led to improved surveillance efforts, enabling faster identification and response to potential outbreaks.

This greater focus on disease monitoring drives the arbovirus testing market, as governments and health organizations prioritize timely detection to control the spread of these infections.

Arbovirus testing has emerged as a pivotal tool in preventing the spread of these Neglected Tropical Diseases (NTDs). According to WHO estimates, around one-fifth of the population-about 1.7 billion people, mostly in developing and low-income nations-must receive diagnosis and treatment for at least one noncommunicable disease annually. The dengue and chikungunya NTD epidemic impacted almost 40% of Africa. These illnesses are more common in impoverished communities in tropical and hard-to-reach locations due to a favorable environment for virus growth and lack of hygiene. Thus, most NTD cases are reported from Brazil, Yemen, India, Bangladesh, China and several countries in Central and East Africa. Thus, the rising incidence of dengue and chikungunya is anticipated to fuel the demand for arbovirus testing, thereby driving market growth.

Moreover, several international organizations run programs to raise awareness of NTDs, including the United States Global Health Initiative, the Global NTD Program by the Centers for Disease Control and Prevention, the World Health Organization's Global NTD Programs, and the NTD Program by the United States Agency for International Development. These programs focus mainly on reducing or eliminating NTDs such as dengue and chikungunya. In addition, the WHO introduced a pilot program for a WHO Expert Review Panel for Diagnostic Products (ERPD) for NTDs in October 2023. This program focuses on enhancing the quality control and availability of NTD diagnostic tools for medical professionals.

Global Arbovirus Testing Market Report: Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, the analyst has segmented the global arbovirus testing market report on the basis of type, end-use, and region:

Type Outlook (Revenue, USD Million, 2018-2030)

  • ELISA-based Tests
  • RT-PCR Based Tests
  • Other Test Types

End Use Outlook (Revenue, USD Million, 2018-2030)

  • Diagnostic Laboratories
  • Hospitals
  • Research Centers
  • Other End Use

Regional Outlook (Revenue, USD Million, 2018-2030)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.2.3. Regional Scope
1.2.4. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Outlook
2.2.2. End Use Outlook
2.2.3. Regional Outlook
2.3. Competitive Scenario
Chapter 3. Arbovirus Testing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Arbovirus Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. Arbovirus Testing Market: Type Estimates & Trend Analysis
4.1. Type Segment Dashboard
4.2. Arbovirus Testing Market: Type Movement Analysis
4.3. Global Arbovirus Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. ELISA-Based Tests
4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5. RT-PCR Based Tests
4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.6. Other Test Types
4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Arbovirus Testing Market: End Use Estimates & Trend Analysis
5.1. End Use Segment Dashboard
5.2. Arbovirus Testing Market: End Use Movement Analysis
5.3. Global Arbovirus Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Diagnostic Laboratories
5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5. Hospitals
5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6. Research Centers
5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.7. Other End Use
5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Arbovirus Testing Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. Arbovirus Testing Market by Region: Key Takeaways
6.4. North America
6.4.1. U.S.
6.4.1.1. Key Country Dynamics
6.4.1.2. Regulatory Framework/ Reimbursement Structure
6.4.1.3. Competitive Scenario
6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework/ Reimbursement Structure
6.4.2.3. Competitive Scenario
6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.3. Mexico
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework/ Reimbursement Structure
6.4.3.3. Competitive Scenario
6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5. Europe
6.5.1. Germany
6.5.1.1. Key Country Dynamics
6.5.1.2. Regulatory Framework/ Reimbursement Structure
6.5.1.3. Competitive Scenario
6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. U.K.
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework/ Reimbursement Structure
6.5.2.3. Competitive Scenario
6.5.2.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework/ Reimbursement Structure
6.5.3.3. Competitive Scenario
6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework/ Reimbursement Structure
6.5.4.3. Competitive Scenario
6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework/ Reimbursement Structure
6.5.5.3. Competitive Scenario
6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.6. Denmark
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework/ Reimbursement Structure
6.5.6.3. Competitive Scenario
6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.7. Sweden
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework/ Reimbursement Structure
6.5.7.3. Competitive Scenario
6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.8. Norway
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework/ Reimbursement Structure
6.5.8.3. Competitive Scenario
6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Regulatory Framework/ Reimbursement Structure
6.6.1.3. Competitive Scenario
6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. China
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework/ Reimbursement Structure
6.6.2.3. Competitive Scenario
6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.3. India
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework/ Reimbursement Structure
6.6.3.3. Competitive Scenario
6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework/ Reimbursement Structure
6.6.4.3. Competitive Scenario
6.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework/ Reimbursement Structure
6.6.5.3. Competitive Scenario
6.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework/ Reimbursement Structure
6.6.6.3. Competitive Scenario
6.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework/ Reimbursement Structure
6.7.2.3. Competitive Scenario
6.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework/ Reimbursement Structure
6.7.3.3. Competitive Scenario
6.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework/ Reimbursement Structure
6.8.2.3. Competitive Scenario
6.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework/ Reimbursement Structure
6.8.3.3. Competitive Scenario
6.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework/ Reimbursement Structure
6.8.4.3. Competitive Scenario
6.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework/ Reimbursement Structure
6.8.5.3. Competitive Scenario
6.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company/ Competition Categorization
7.3. Vendor Landscape
7.3.1. Key Company Heat Map Analysis, 2024
7.4. Company Profiles
7.4.1. Abbott
7.4.1.1. Company Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Thermo Fisher Scientific Inc.
7.4.2.1. Company Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. NovaTec Immundiagnostica GmbH (Gold Standard Diagnostics Frankfurt GmbH)
7.4.3.1. Company Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Agilent Technologies, Inc.
7.4.4.1. Company Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. EUROIMMUN Medical Laboratory Diagnostics AG
7.4.5.1. Company Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Merck KGaA
7.4.6.1. Company Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. F. Hoffmann-La Roche Ltd
7.4.7.1. Company Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Siemens Healthineers AG
7.4.8.1. Company Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. QIAGEN
7.4.9.1. Company Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Bio-Rad Laboratories, Inc.
7.4.10.1. Company Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Arbovirus Testing Market, by Region, 2018-2030 (USD Million)
Table 4. Global Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 5. Global Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 6. North America Arbovirus Testing Market, by Country, 2018-2030 (USD Million)
Table 7. North America Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 8. North America Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 9. U.S. Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 10. U.S. Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 11. Canada Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 12. Canada Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 13. Mexico Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 14. Mexico Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 15. Europe Arbovirus Testing Market, by Country, 2018-2030 (USD Million)
Table 16. Europe Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 17. Europe Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 18. Germany Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 19. Germany Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 20. U.K. Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 21. U.K. Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 22. France Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 23. France Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 24. Italy Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 25. Italy Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 26. Spain Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 27. Spain Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 28. Denmark Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 29. Denmark Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 30. Sweden Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 31. Sweden Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 32. Norway Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 33. Norway Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 34. Asia Pacific Arbovirus Testing Market, by Country, 2018-2030 (USD Million)
Table 35. Asia Pacific Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 36. Asia Pacific Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 37. Japan Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 38. Japan Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 39. China Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 40. China Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 41. India Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 42. India Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 43. South Korea Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 44. South Korea Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 45. Australia Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 46. Australia Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 47. Thailand Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 48. Thailand Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 49. Latin America Arbovirus Testing Market, by Country, 2018-2030 (USD Million)
Table 50. Latin America Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 51. Latin America Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 52. Brazil Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 53. Brazil Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 54. Argentina Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 55. Argentina Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 56. Middle East & Africa Arbovirus Testing Market, by Country, 2018-2030 (USD Million)
Table 57. Middle East & Africa Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 58. Middle East & Africa Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 59. South Africa Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 60. South Africa Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 61. Saudi Arabia Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 62. Saudi Arabia Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 63. UAE Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 64. UAE Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
Table 65. Kuwait Arbovirus Testing Market, by Type, 2018-2030 (USD Million)
Table 66. Kuwait Arbovirus Testing Market, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 QFD Modeling for Market Share Assessment
Figure 8 Market Formulation & Validation
Figure 9 Arbovirus Testing Market: Market Outlook
Figure 10 Arbovirus Testing Competitive Insights
Figure 11 Parent Market Outlook
Figure 12 Related/Ancillary Market Outlook
Figure 13 Penetration and Growth Prospect Mapping
Figure 14 Industry Value Chain Analysis
Figure 15 Arbovirus Testing Market Driver Impact
Figure 16 Arbovirus Testing Market Restraint Impact
Figure 17 Arbovirus Testing Market Strategic Initiatives Analysis
Figure 18 Arbovirus Testing Market: Type Movement Analysis
Figure 19 Arbovirus Testing Market: Type Outlook and Key Takeaways
Figure 20 ELISA-Based Tests Market Estimates and Forecast, 2018-2030
Figure 21 RT-PCR Based Tests Market Estimates and Forecast, 2018-2030
Figure 22 Other Test Types Market Estimates and Forecast, 2018-2030
Figure 23 Arbovirus Testing Market: End Use Movement Analysis
Figure 24 Arbovirus Testing Market: End Use Outlook and Key Takeaways
Figure 25 Diagnostic Laboratories Market, 2018-2030 (USD Million)
Figure 26 Hospitals Market, 2018-2030 (USD Million)
Figure 27 Research Centers Market, 2018-2030 (USD Million)
Figure 28 Other End Use Market, 2018-2030 (USD Million)
Figure 29 Global Arbovirus Testing Market: Regional Movement Analysis
Figure 30 Global Arbovirus Testing Market: Regional Outlook and Key Takeaways
Figure 31 North America Market Estimates and Forecasts, 2018-2030
Figure 32 U.S. Market Estimates and Forecasts, 2018-2030
Figure 33 Canada Market Estimates and Forecasts, 2018-2030
Figure 34 Mexico Market Estimates and Forecasts, 2018-2030
Figure 35 Europe Market Estimates and Forecasts, 2018-2030
Figure 36 Germany Market Estimates and Forecasts, 2018-2030
Figure 37 U.K. Market Estimates and Forecasts, 2018-2030
Figure 38 France Market Estimates and Forecasts, 2018-2030
Figure 39 Italy Market Estimates and Forecasts, 2018-2030
Figure 40 Spain Market Estimates and Forecasts, 2018-2030
Figure 41 Denmark Market Estimates and Forecasts, 2018-2030
Figure 42 Sweden Market Estimates and Forecasts, 2018-2030
Figure 43 Norway Market Estimates and Forecasts, 2018-2030
Figure 44 Asia Pacific Market Estimates and Forecasts, 2018-2030
Figure 45 Japan Market Estimates and Forecasts, 2018-2030
Figure 46 China Market Estimates and Forecasts, 2018-2030
Figure 47 India Market Estimates and Forecasts, 2018-2030
Figure 48 South Korea Market Estimates and Forecasts, 2018-2030
Figure 49 Australia Market Estimates and Forecasts, 2018-2030
Figure 50 Thailand Market Estimates and Forecasts, 2018-2030
Figure 51 Latin America Market Estimates and Forecasts, 2018-2030
Figure 52 Brazil Market Estimates and Forecasts, 2018-2030
Figure 53 Argentina Market Estimates and Forecasts, 2018-2030
Figure 54 Middle East & Africa Market Estimates and Forecasts, 2018-2030
Figure 55 South Africa Market Estimates and Forecasts, 2018-2030
Figure 56 Saudi Arabia Market Estimates and Forecasts, 2018-2030
Figure 57 UAE Market Estimates and Forecasts, 2018-2030
Figure 58 Kuwait Market Estimates and Forecasts, 2018-2030

Companies Mentioned

The companies profiled in this Arbovirus Testing market report include:
  • Abbott
  • Thermo Fisher Scientific Inc.
  • NovaTec Immundiagnostica GmbH (Gold Standard Diagnostics Frankfurt GmbH)
  • Agilent Technologies, Inc.
  • EUROIMMUN Medical Laboratory Diagnostics AG
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • QIAGEN
  • Bio-Rad Laboratories, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedApril 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.43 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Arbovirus Testing Market by Type, Component, Indication, End-User - Global Forecast 2025-2030 - Product Image

Arbovirus Testing Market by Type, Component, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Arbovirus Testing Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Arbovirus Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Arbovirus Testing - Global Strategic Business Report - Product Image

Arbovirus Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 172 Pages
  • Global
Arbovirus Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Arbovirus Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.